New Delhi, March 21 Indian pharmaceutical companies Sun Pharma, Dr Reddy's, and Glenmark announced on Saturday the launch of their generic versions of semaglutide injection, used for diabetes and weight management, following the expiration of patents on products like Ozempic and Wegovy in India...
New Delhi, March 18 Zydus Lifesciences and Torrent Pharmaceuticals have signed a licensing and supply agreement to co-market the diabetes treatment medication Semaglutide Injection in the Indian market.Under the terms of the agreement, Zydus will manufacture and supply the product, while...
New Delhi, March 17 Zydus Lifesciences announced on Tuesday that it has entered into a licensing and supply agreement with Lupin to expand access to the diabetes treatment drug Semaglutide Injection (15 mg/3 ml) with a patient-friendly, reusable pen device in India.The agreement aims to...
New Delhi, March 14 Zydus Lifesciences announced on Saturday that its innovative drug has received approval from China's National Medical Products Administration (NMPA) for its Desidustat tablets, used to treat renal anemia.The company has licensed its Desidustat tablets to a subsidiary of...
china
china medical system
chronic kidney disease
ckd
desidustat
drug approval
greater china
healthcare
kidney failure
licensing
medical products
medicine
oxemia
patient outcomes
renal anemia
zyduslifesciences
New Delhi, February 28 Zydus Lifesciences announced on Saturday that it has received approval from the US health regulator to market generic anti-parasitic and leprosy medications.The company has received final approvals from the US Food and Drug Administration (USFDA) for Ivermectin Tablets...
New Delhi, February 19 Zydus Lifesciences announced on Thursday that it has launched its first biosimilar, developed indigenously, for the treatment of visual impairment.Anyra, the country's first biosimilar of Aflibercept 2 mg, is indicated for the treatment of visual impairment caused by...
aflibercept
anyra
bayer
biologics
biosimilar
diabetes
drug development
gujarat
healthcare
india
ophthalmic care
pharmaceuticals
regeneron pharmaceuticals
visual impairment
zyduslifesciences
New Delhi, February 17 Zydus Lifesciences announced on Tuesday that it has launched a device to help clear congestion, support effective mucus clearance, and improve breathing in patients with COPD, asthma, and bronchiectasis.The company has launched PEPAIR, India's first affordable...
New Delhi, February 12 Zydus Lifesciences announced on Thursday that it will pay USD 120 million to Astellas Pharma to settle a patent dispute over a medication for treating an overactive bladder.Zydus Pharmaceuticals USA, Inc, a wholly-owned subsidiary of the company, has entered into a...
New Delhi, February 11 The Supreme Court on Wednesday refused to restrain Zydus Lifesciences from selling its affordable, generic biosimilar of Nivolumab, a life-saving cancer drug registered by Bristol Myers Squibb (BMS).A bench of Chief Justice Surya Kant and Justice Joymalya Bagchi was...
New Delhi, February 9 Zydus Lifesciences Ltd on Monday reported a 1.81 per cent increase in consolidated net profit at Rs 1,042.1 crore for the quarter ended December 31, 2025.The company had posted a consolidated net profit of Rs 1,023.5 crore in the corresponding quarter of the previous...